Emphasis

A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines (EMPHASIS-HF)

Stage
klaar
Medicine
inspra (eplerenone)
Population
Hartfalen
Phase
III
First Patient In
1 January 2005
Last Patient In
-
Last Patient Last Visit
-

Study Director

dr. P.H.J.M. Dunselman †

Cardioloog

The page has expired.